ENDS Respiratory System: Difference between revisions
Richardpruen (talk | contribs) Marked this version for translation |
adding content |
||
| Line 231: | Line 231: | ||
=2nd Hand Vapor= <!--T:56--> | =2nd Hand Vapor= <!--T:56--> | ||
===2022: [https://link.springer.com/article/10.1007/s11739-022-03061-2 Computational modeling method to estimate secondhand exposure potential from exhalations during e-vapor product use under various real-world scenarios]=== | |||
*Acetaldehyde and acrolein were not detectable after use of any of the test products. | |||
*When these data were used as inputs to a computational room air level and non-user intake model, the ambient concentrations of exhaled nicotine and formaldehyde predicted that non-user intakes were substantially reduced for test product use compared to conventional cigarette use. | |||
*Collectively, the results predict that room air levels and exposure of the selected analytes to non-users were relatively low and several-fold below regulatory PELs and AIHA limit under the modeled space and use conditions. | |||
*...room air levels of nicotine, formaldehyde, acrolein, and acetaldehyde levels were significantly below OSHA PELs or American Industrial Hygiene Association (AIHA) limit... | |||
| Line 273: | Line 279: | ||
Non-cancer risk analysis revealed “No Significant Risk” of harm to human health for vapor samples from e-liquids. | Non-cancer risk analysis revealed “No Significant Risk” of harm to human health for vapor samples from e-liquids. | ||
With regard to cancer risk analysis, no vapor sample from e-liquids exceeded the risk limit for either children or adults. | With regard to cancer risk analysis, no vapor sample from e-liquids exceeded the risk limit for either children or adults. | ||
<br> | |||
=PAGE EDITORS - Please add Studies, Surveys, Papers in this format to keep page organized= <!--T:67--> | =PAGE EDITORS - Please add Studies, Surveys, Papers in this format to keep page organized= <!--T:67--> | ||